Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CALIPSO: Antimicrobial Prophylaxis Duration in Cardiac Surgery
NCT05447559Phase 4Recruiting
- Sponsor
- Monash University
- Start
- Feb 2023
- Primary completion
- Dec 2027
- Modality
- Reversible Covalent Inhibitors
- Countries
- 5
01
Overview
A Phase 4 trial of cefazolin in surgical site infection (SSI), sponsored by Monash University. Started Feb 2023; status: recruiting.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT05447559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05447559.